News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Regnante Keith
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Regnante Keith (CFO) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Sold 17,301 shares
@ $47.66, valued at
$824.6k
Sold 2,699 shares
@ $48.65, valued at
$131.3k
Sold 15,993 shares
@ $45.03, valued at
$720.2k
Sold 1,428 shares
@ $46.46, valued at
$66.3k
Sold 2,579 shares
@ $47.25, valued at
$121.9k
Exercised 20,000 options to buy
@ $16, valued at
$320k
Exercised 20,000 options to buy
@ $16, valued at
$320k
|
|
| 06/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/25/2022 |
4
| Regnante Keith (CFO) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $46.3, valued at
$2.3M
|
|
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2020 |
4
| Regnante Keith (CFO) has filed a Form 4 on Keros Therapeutics, Inc.|
Txns:
| Granted 18,430 options to buy
@ $16, valued at
$294.9k
Granted 133,622 options to buy
@ $16, valued at
$2.1M
|
|
| 04/07/2020 |
3
| Regnante Keith (CFO) has filed a Form 3 on Keros Therapeutics, Inc. |
| 03/11/2019 |
4
| Regnante Keith (CFO) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 13,500 shares
@ $0 |
|
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2018 |
4
| Regnante Keith (CFO) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Sold 316 shares
@ $51.85, valued at
$16.4k
|
|
| 01/25/2018 |
4
| Regnante Keith (CFO) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 13,000 shares
@ $0
Granted 26,000 options to buy
@ $40.05, valued at
$1M
|
|
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2016 |
4
| Regnante Keith (CFO) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 120,000 options to buy
@ $20.89, valued at
$2.5M
|
|
| 08/17/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|